一种新的CLTC变种改变RNA拼接,导致胎儿发育异常
Chen Cheng1, Fan Yang1, Sheng Zhao2
1Ultrasound Diagnosis Department, Maternal and Child Health Hospital of Hubei Province, Wuhan, 430070, China.
BMC medical genomics
|December 19, 2023
概括
在胎儿中发现了一种新的CLTC基因变异,呈现出早期产前症状,如脑囊和心脏缺陷. 这一发现扩大了对与CLTC相关的智力发育障碍的理解.
科学领域:
- 遗传学 是一个遗传学.
- 发展生物学 发展生物学
- 医学诊断 医学诊断 医学诊断
背景情况:
- CLTC 变种很少见,全球报告了 ~31 个病例,所有病例都表现出运动和精神障碍.
- CLTC与智力发育障碍相关,自体主导56.
- 关于CLTC相关疾病的产前表现的研究有限.
研究的目的:
- 在产前病例中识别和表征一种新的CLTC变种.
- 为了研究与CLTC变种相关的产前表型.
- 阐明新发现的CLTC变异对RNA剪接和蛋白质表达的功能后果.
主要方法:
- 产前超声波用于表型评估.
- 整体外基因组测序用于变种识别.
- 变体有害性的计算预测.
- 功能分析的迷你基因测定和西部斑点.
主要成果:
- 在一个胎儿中发现了一种新型的异质合体 de novo CLTC 变体 (c.3249 + 1G > C).
- 产前超声检查显示了双边胆结囊,高性脏和心室隔膜缺陷.
- 功能性研究表明,该变体破坏了RNA拼接,导致截断转录和蛋白质降解.
结论:
- 这项研究报告了在产前阶段的CLTC变种最早已知的临床特征.
- 鉴定到的CLTC变体改变了RNA剪接和蛋白质表达,导致了这种疾病.
- 这些发现扩大了已知的CLTC突变谱,并为遗传咨询提供了指导.
相关概念视频
RNA Splicing
56.4K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.4K
Alternative RNA Splicing
21.2K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.2K
Translation
14.9K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
Translation Produces the Building Blocks of Life
Proteins are...
14.9K
Teratogenicity
2.5K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K
Leaky Scanning
5.1K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.1K
Non-LTR Retrotransposons
11.5K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.5K


